==== Front
Molecules
Molecules
molecules
Molecules
1420-3049 MDPI 

33260745
10.3390/molecules25235595
molecules-25-05595
Article
A General and Scalable Synthesis of Polysubstituted Indoles
Tejedor David 1* Diana-Rivero Raquel 12 https://orcid.org/0000-0001-6470-6289García-Tellado Fernando 1* 1 Instituto de Productos Naturales y Agrobiología, Consejo Superior de Investigaciones Científicas, Astrofísico Francisco Sánchez 3, 38206 La Laguna, Spain; raquel.diana.rivero@gmail.com
2 Doctoral and Postgraduate School, Universidad de La Laguna, Apartado Postal 456, 38200 La Laguna, Spain
* Correspondence: dtejedor@ipna.csic.es (D.T.); fgarcia@ipna.csic.es (F.G.-T.)
28 11 2020 
12 2020 
25 23 559503 11 2020 26 11 2020 © 2020 by the authors.2020Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).A consecutive 2-step synthesis of N-unprotected polysubstituted indoles bearing an electron-withdrawing group at the C-3 position from readily available nitroarenes is reported. The protocol is based on the [3,3]-sigmatropic rearrangement of N-oxyenamines generated by the DABCO-catalyzed reaction of N-arylhydroxylamines and conjugated terminal alkynes, and delivers indoles endowed with a wide array of substitution patterns and topologies.

indolindole-3-carboxylatesindole-3-carboxyamides3-aroylindoles3-acylindolesN-oxyenamines[3,3]-sigmatropic rearrangementannulationDABCOorganocatalysis
==== Body
1. Introduction
The indole moiety occupies a privileged place in the realm of heterocyclic chemistry [1]. It constitutes the core structure of many natural products and synthetic bioactive compounds exhibiting a wide array of biological activities [2,3,4,5,6], and has also found use as structural parts of material science devices [7,8,9] and chiral catalysts [10,11,12]. Recent studies have shown that the substitution at the C-3 position with electron-withdrawing groups (3-EWG-indoles) not only endows these structures with important pharmaceutical/therapeutic activities [13,14,15,16,17,18,19,20,21], but also it converts them into versatile synthetic molecular platforms in heterocyclic chemistry, such as, in dearomatization-based synthetic disconnections [22]. The catalytic asymmetric dearomatization of 3-nitroindoles constitutes an iconic example of this synthetic potential [23,24,25,26,27,28,29,30,31,32,33,34]. The most traditional synthetic approach to these functionalized indoles relies on the Friedel–Crafts acylation of preformed indoles [35,36,37]. This transformation suffers important drawbacks such as mandatory nitrogen protection, regioselectivity control, stoichiometric use of metal salts and Lewis acid promoters, and strict exclusion of moisture. Although modern alternatives using metal-catalysis [38,39,40,41,42] or photocatalysis [43,44,45,46] have overcome some of these difficulties, the implementation of real-world strategies to prepare these heterocycles from simple and widely accessible starting materials remains a synthetic challenge in medicinal and synthetic chemistry. In spite of the many advances achieved in the synthesis of indoles during the last 100 years [47], the de novo synthesis of 3-EWG-indoles remains largely unexplored. A large number of strategies for the synthesis of indoles use alkynes and a convenient nitrogen source as substrates [48] and the annelation of the five-membered ring to an existing functionalized benzene ring as the main synthetic disconnection [49]. The inherent alkyne reactivity and the broad access to nitrogen sources constitute practical advantages for these strategies. Among them, the [3,3]-sigmatropic rearrangement of N-oxyenamines [50] or 1-aryl-2-vinylhydrazines [51,52] have been objects of profuse research (Scheme 1a). Prototypical examples of these strategies constitute the Bartoli [53,54] (N-oxyenamines) and the Fischer [55] (1-aryl-2-vinylhydrazines) syntheses of indoles. Although both reactions have been largely used in the preparation of indoles [47], they present important drawbacks for general preparative synthetic use. Whereas those based on the Fischer disconnection suffer the limitations associated with the hydrazine synthesis and drastic reaction conditions, the Bartoli method, although synthetically powerful, requires the use of ortho-substituted nitroarenes and functional tolerance to Grignard reagents. Recently, an elegant example of the use of the N-oxyenamine disconnection to gain access to polysusbtituted indoles has been reported by Zhang and co-workers (Scheme 1b) [56]. The methodology uses the Zn/Au-catalyzed reaction of N-protected N-arylhydroxamic acids (or N-aryl-N-hydroxycarbamates) 1 and alkynes to construct the indole core with a diverse pattern of substitution at both rings. Although the methodology was effective for the synthesis of alkyl indole-3-carboxylates (2, the unique reported example: Pg = Ac; R1 = CH2CH2Ph, R2 = CO2Me), its extension to other 3-EWG-indoles remains to be assessed [57].

We envisioned that a simpler and general methodology using the N-oxyenamine disconnection could be arranged on the basis of the well-established addition of nucleophiles onto terminal conjugated alkynes catalyzed by tertiary amines (Scheme 1c) [58,59,60,61]. When searching for precedents for this disconnection, we found a reduced number of reported examples, all of them circumscribed to the synthesis of alkyl indole-3-carboxyates [62,63,64,65,66], and with important drawbacks for a practical and general application. They mostly use N-arylhydroxylamine salts or N-protected N-arylhydroxylamines to force the O-addition reaction, and require large excesses of alkyne and long reaction times to deliver the indole-3-carboxylates in low to moderate yields. Therefore, a general and practical protocol for accessing NH-free 3-EWG-indoles based on this disconnection remains to be established. In terms of sustainability, such protocol should be direct, operationally simple and scalable, avoiding non-productive N-protection/N-deprotection steps. We report herein our results on the implementation of a strategy fulfilling these requirements and overcoming the practical shortcomings found in previous reports. The strategy delivers NH-free multisubstituted 3-EWG-indoles through a consecutive 2-step reaction manifold, and it uses nitroarenes and activated terminal alkynes as building blocks (Scheme 1c). The reaction manifold takes advantage of the O-reactivity of N-arylhydroxylamines toward terminal conjugated alkynes and of the rich arsenal of commercially available functionalized nitroarenes. Whereas the first one avoids unnecessary N-protection/N-deprotection steps (step-economy, reagent-economy), the second one offers an almost countless catalogue of functional diversity on the benzene ring (general outcome). These properties make this reaction manifold a convenient, instrumentally simple, robust and reliable synthetic tool for the exploration/annotation of the chemical space of 3-EWG-indoles. 

2. Results and Discussion
2.1. Initial Experiments and Optimization of the Reaction Conditions for a Consecutive 2-Step Protocol
The initial studies began using commercially available N-benzoyl-N-phenylhydroxylamine (4a-N-Bz) as the nitrogen species needed for the synthesis of indoles and the standard conditions reported by our group for the DABCO-catalyzed synthesis of propargyl vinyl ethers [59] (Scheme 2). Although the addition of the hydroxylamine to methyl propiolate (5a) took place in the presence of DABCO, and this was followed by the desired cyclization, the hydroxyindoline intermediate HI was isolated instead of the expected indole 6a-N-Bz. Furthermore, a side-product incorporating a second unit of methyl propiolate was also obtained (DVE). It forms from the DABCO-catalyzed addition of methyl propiolate (5a) on the enol ether generated on the [3,3]sigmatropic rearrangement of the intermediate N-oxyenamine. The overnight reaction of intermediate HI with Et3N afforded the indole 6a-N-Bz in quantitative yield. 

At this time, we decided to question the need for the protecting group on the nitrogen atom. Indeed, when starting from N-phenylhydroxylamine (4a) and methyl propiolate (5a) (1.2 equiv) as the reactants, the reaction proceeded smoothly to the desired unprotected indole 6a (Table 1, entry 1). The observed outcome was different to that reported by Hwu et al. [64] in which N-vinyl protected indoles were obtained when N-phenylhydroxylamine (4a) reacted with an excess of methyl propiolate (5a) in the presence of a catalytic amount of DMAP. Strikingly, the report by Hwu et al. claims that DABCO and Et3N did not give significant amounts of the desired indoles under their reaction conditions.

Once the feasibility of the reaction using free N-phenylhydroxylamine (4a) was established, we next undertook the optimization of the reaction (Table 1). Under all assayed conditions, the formation of the desired indole 6a was accompanied by the formation of very small amounts of side-product DVE. Based on these results, and taking into consideration the simplicity of the experimental procedure, we chose the reaction conditions depicted in entry 4 as the standardized conditions for the formation of the desired indoles 6 from the appropriate N-arylhydroxylamines 4. 

Once this reaction was optimized, we coupled this reaction with the reduction of the nitrobenzene (3a) to set up a consecutive 2-step reaction manifold (Scheme 3). Thus, reduction of nitrobenzene (3a) with hydrazine monohydrate and Rh on activated charcoal (5%) in THF gave N-phenylhydroxylamine (4a), which, after filtration of the reaction mixture and concentration, was directly submitted to the next reaction step to deliver indole 6a in 80% overall yield. Under these conditions, the overall yield of indole 6a was comparable to that obtained directly from 4a (80% vs 82%).

2.2. Scope of the Consecutive 2-Step Protocol
With a convenient protocol in hand, we next explored its scope with regard to the alkyne using N-phenylhydroxylamine (4a) as the nitrogen component (Scheme 4). The reaction was well suited to prepare 3-EWG-indoles incorporating carboxylates (6a–c), aroyl (acyl) groups (6d,e), or carboxamides (6f,g). In the case of N,N-disubstituted propionamides 5f and 5g, the poorest Michael acceptors of the series, the reaction needed more time (overnight) to deliver the corresponding N,N-disubstituted indole-3-carboxamides 6f and 6g in synthetically relevant 52% and 58% yields respectively. The efficiency and simplicity of this transformation are emphasized when compared with the current multistep methodologies to prepare these indole-3-carboxamides [67].

The scope of the consecutive 2-step manifold with regard to the substitution at the benzene ring was explored using methyl propiolate (5a) as the alkyne component and differently substituted nitroarenes 3 (Scheme 5). The manifold tolerated a diverse substitution pattern on the benzene ring to deliver the corresponding methyl indole-3-carboxylates 6 with overall good efficiency and broad functional/structural diversity. A convenient grade of topological diversity could be generated, spanning from the simple monosubstituted derivatives (e.g., 6h–r, 52–90% yield) to more complex polycyclic (6w, 57%) or fused aromatic systems (6ac, 83%). Meta-substituted N-arylhydroxylamines afforded separable mixtures of the corresponding C-4/C-6 regioisomers in excellent yields (80–90%) and with a slight substituent- dependent regioselectivity (Scheme 5, compounds 6n–r). A balance between steric and electronic effects of the substituent seems to steer the outcome of the [3,3]-sigmatropic rearrangement, in line with the reported results in the Fischer synthesis of indoles endowed with this substitution pattern [52,65,68]. Thus, electron-donating substituents (R = OMe) unbalanced the chemical outcome towards the less crowed isomer (6r, 1.7:1 / C-6: C-4 ratio) whereas electron-withdrawing groups did it in the opposite direction (6o–q; from 1:1 to 2.3:1 / C-4:C-6 ratio). It is remarkable that the [3,3]-sigmatropic rearrangement of benzyl ketene acetals bearing a meta-OMe substituent on the aromatic ring preponderantly delivers the C-4 isomer. Theoretical studies pointed to a stabilizing interaction between the lone pair of the substituent and the LUMO orbital of the transition state as being responsible for the observed regioselectivity [69]. The observed inverted regioselectivity in our reaction seems to rule out the existence of this kind of stabilizing interactions. 

As expected, substitution at the ortho-position posed a regioselectivity problem in the [3,3]-sigmatropic rearrangement, since the C-C bond formation at the most substituted ortho-position becomes a competitive pathway (Scheme 6). Indeed, in some cases, we were able to isolate the product 10 obtained from this pathway. The effect of this mechanistic divergence was mainly reflected in a diminished efficiency in the reactions of nitroarenes bearing a good leaving group at that position (6x–z, 6aa–ab). In the case of simple alkyl substituents (6s–u) or fused bicycles (6w), the manifold mostly afforded the expected C-7 substituted indole derivatives in moderate to good yields. The versatility of this methodology is highlighted when compared with Zhangs’ protocol [56] (Scheme 1B), which is sensitive to steric impediments and shows a reduced tolerance to alkyl substitution at this position [70]. However, the easy access to ortho-substituted nitroarenes together with the simplicity of the 2-step reaction manifold compensate for these deficiencies and make this methodology a viable synthetic alternative to prepare C-7 substituted 3-EWG indoles. 

The reaction manifold was well suited to scale up. As a proof of concept, we carried out the synthesis of methyl 6-acetylindole-3-carboxylate (6m) at 50 mmol scale from 4-acetylnitrobenzene (3m) and methyl propiolate (5a). The scaled manifold afforded indole 6m in an excellent 84% yield (9.08 g) (Scheme 5).

Finally, the anticancer activity of some 3-aroyl indoles [17,19] led us to evaluate our methodology as a novel and practical access to the chemical/therapeutic space of these derivatives. Among the huge number of possible 3-aroylindoles, we chose (6-methoxy-1H-indole-3-yl) (3,4,5-trimethoxyphenyl) methanone, the so-called BPRL0T075 (6ad, box in Scheme 5), an extremely potent cytotoxic compound with good pharmacological properties [21]. The manifold delivered it in a 30% yield along with its C-4 isomer (25%).

3. Materials and Methods 
3.1. General Information
1H-NMR and 13C-NMR spectra (see supplementary materials) of DMSO-d6 or CDCl3 solutions were recorded either at 400 and 100 MHz or at 500 and 125 MHz (Bruker Ac 200 and AMX2-500 respectively). Mass spectra (low resolution) (EI/CI) were obtained with a Hewlett-Packard 5995 gas chromatograph/mass spectrometer. High-resolution mass spectra were recorded with a Micromass Autospec mass spectrometer. Analytical thin-layer chromatography plates used were E. Merck Brinkman UV-active silica gel (Kieselgel 60 F254) on aluminum. Flash column chromatography was carried out with E. Merck silica gel 60 (particle size less than 0.020 mm) using appropriate mixtures of ethyl acetate and hexanes, or ethyl acetate and dichloromethane as eluents. All reactions were performed in oven-dried glassware. All materials were obtained from commercial suppliers and used as received. N-phenylhydroxylamine (4a) was prepared on a multigram scale following a standard experimental procedure [71]. 

3.2. General Procedure for the Synthesis of Indoles 6 Directly from N-phenylhydroxylamine (4a). Preparation of Methyl Indol-3-carboxylate (6a)
To a solution of N-phenylhydroxylamine (4a) (436 mg, 4.0 mmol) in dichloromethane (20 mL) was added the activated alkyne 5 (4.2 mmol) and the resulting solution was cooled to 0 °C using an ice bath. DABCO (22 mg, 0.2 mmol) was added all at once and the reaction mixture was stirred for 1 h. The solvent was removed under reduced pressure, and the residue was purified by flash column chromatography (silica gel; n-hexane/ethyl acetate: 70/30 v/v) to give indole 6a (565.2 mg, 80%). Off-white solid: 1H-NMR (CDCl3, 400 MHz): δ = 3.93 (s, 3H), 7.25–7.28 (m, 2H), 7.40–7.42 (m, 1H), 7.91 (d, 1H, J = 3.0 Hz), 8.18-8.20 (m, 1H), 8.82 (bs, 1H). 13C-NMR (CDCl3, 100 MHz): δ = 51.1, 108.7, 111.5, 121.5, 122.0, 123.2, 125.6, 131.1, 136.1, 165.8 ppm. The values are in accordance with the literature [72].

3.3. General Procedure for the Consecutive 2-Step Synthesis of Indoles 6 from Nitroarenes 3. Preparation of Methyl Indol-3-carboxylate (6a) 
Under a nitrogen atmosphere, the nitrobenzene (3a) (4 mmol) was dissolved in dry tetrahydrofuran (20 mL) and Rh/C (5%) (20 mg) was added to the solution. The resulting mixture was cooled to 0 °C, hydrazine monohydrate (250 mg, 5 mmol) was then added dropwise and the reaction was stirred at 0 °C for 3 h. The reaction mixture was filtered through a short pad of celite (aided with the use of dichloromethane) and the solvents evaporated under reduced pressure. The resulting crude product was dissolved in dichloromethane (20 mL) and methyl propiolate (5a) (344 mg, 4.2 mmol) was added. The resulting solution was cooled to 0 °C using an ice bath and DABCO (22 mg, 0.2 mmol) was added at once. The reaction mixture was stirred for 1 h and the solvent was removed under reduced pressure. The crude residue was purified by flash column chromatography (silica gel; n-hexane/ethyl acetate: 70/30 v/v) to give indole 6a [72].

3.4. Characterization Data for Indoles 6 and 3,3a-Dihydro-2H-Indoles 10
Ethyl 1H-indole-3-carboxylate (6b) (330.2 mg, 87%). Off-white solid: 1H-NMR (DMSO-d6, 500 MHz): δ = 1.33 (t, 3H, J = 7.1 Hz), 4.28 (q, 2H, J = 7.1 Hz), 7.16–7.21 (m, 2H), 7.47 (dd, 1H, J = 6.5 and 1.6 Hz), 8.00 (dd, 1H, J = 6.8 and 2.0 Hz), 8.06 (d, 1H, J = 2.3 Hz), 11.90 (bs, 1H). 13C-NMR (DMSO-d6, 125 MHz): δ = 14.5, 59.0, 106.6, 112.3, 120.5, 121.2, 122.3, 125.6, 132.4, 136.4, 164.4 ppm. The values are in accordance with the literature [73].

Octyl 1H-indole-3-carboxylate (6c) (217.5 mg, 80%). Off-white solid: 1H-NMR (CDCl3, 400 MHz): δ = 0.88 (t, 3H, J = 6.8 Hz), 1.28–1.39 (m, 8H), 1.43–1.47 (m, 2H), 1.76–1.83 (m, 2H), 4.34 (t, 2H, J = 6.6 Hz), 7.24–7.29 (m, 2H), 7.39–7.42 (m, 1Hz), 7.91 (d, 1H, J = 2.1 Hz), 8.16–8.20 (m, 1H), 8.80 (bs, 1H). 13C-NMR (CDCl3, 100 MHz): δ = 14.0, 22.6, 26.2, 29.0, 29.2, 29.3, 31.8, 64.1, 109.2, 111.5, 121.6, 122.0, 123.1, 125.8, 131.0, 136.2, 165.5 ppm. HRMS (ESI-) m/z [M-H]− calculated for C17H22NO2 272.1651, found 272.1650.

(1H-Indol-3-yl)(phenyl)methanone (6d) (351.4 mg, 83%). Off-white solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 7.22–7.28 (m, 2H), 7.52–7.62 (m, 4H), 7.78–7.80 (m, 2H), 7.93 (s, 1H), 8.26 (dd, 1H, J = 6.7 and 1.7 Hz), 12.10 (bs, 1H). 13C-NMR (DMSO-d6, 100 MHz): δ = 112.2, 115.0, 121.4, 121.9, 123.1, 126.2, 128.3, 128.4, 131.0, 136.7, 140.5, 190.0 ppm. The values are in accordance with the literature [74].

1-(1H-Indol-3-yl)hexan-1-one (6e) (144.5 mg, 67%). Off-white solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 0.87 (t, 3H, J = 6.8 Hz), 1.29–1.34 (m, 4H), 1.60–1.68 (m, 2H), 2.82 (t, 2H, J = 7.4 Hz), 7.14–7.22 (m, 2H), 7.45–7.47 (m, 1H), 8.20 (dd, 1H, J = 6.9 and 1.5 Hz), 8.30 (d, 1H, J = 3.0 Hz), 11.88 (bs, 1H). 13C-NMR (DMSO-d6, 100 MHz): δ = 13.9, 22.0, 24.6, 31.1, 38.7, 112.0, 116.4, 121.4, 121.5, 122.6, 125.4, 133.6, 136.6, 195.5 ppm. The values are in accordance with the literature [75].

N-cyclohexyl-1H-indole-3-carboxamide (6f) (127.1 mg, 52%). The reaction time was increased to overnight. Off-white solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 1.12–1.36 (m, 5H), 1.60–1.63 (m, 1H), 1.70–1.77 (m, 2H), 1.82–1.88 (m, 2H), 3.86–4.08 (m, 1H), 7.06–7.14 (m, 2H), 7.40 (d, 1H, J = 8.0 Hz), 7.60 (d, 1H, J = 6.1 Hz), 8.05 (s, 1H), 8.14 (d, 1H, J = 7.8 Hz), 11.5 (bs, 1H). 13C-NMR (DMSO-d6, 100 MHz): δ = 25.0 (2C), 25.4, 32.9 (2C), 47.4, 110.8, 111.6, 120.1, 121.1, 121.7, 126.3, 127.5, 136.1, 163.7 ppm. HRMS (ESI+) m/z [M + Na]+ calculated for C15H18N2ONa 265.1317, found 265.1314.The product had been previously described in the literature but in CDCl3 [76].

N-Methyl-N-phenyl-1H-indole-3-carboxamide (6g) (290.4 mg, 58%). The reaction time was increased to overnight. Off-white solid: 1H-NMR (DMSO-d6, 500 MHz): δ = 3.36 (s, 3H), 6.36 (d, 1H, J = 3.0 Hz), 7.07 (dd, 1H, J = 7.4 and 1.2 Hz), 7.11 (dd, 1H, J = 7.5 and 1.5 Hz), 7.28–7.32 (m, 4H), 7.37–7.40 (m, 2H), 8.04 (d, 1H, J = 8.0 Hz), 11.28 (bs, 1H). 13C-NMR (DMSO-d6, 125 MHz): δ = 37.9, 109.6, 111.5, 120.3, 121.3, 121.9, 126.8, 127.2, 127.5 (2C), 128.9, 129.4 (2C), 135.1, 145.5, 165.1 ppm. The values are in accordance with the literature [77].

Methyl 5-methyl-1H-indole-3-carboxylate (6h) (533.5 mg, 77%). Off-white solid: 1H-NMR (CDCl3, 400 MHz): δ = 2.48 (s, 3H), 3.92 (s, 3H), 7.08 (dd, 1H, J = 8.3 and 1.2 Hz), 7.29 (d, 1H, J = 8.3 Hz), 7.86 (d, 1H, J = 3.0 Hz), 7.98 (d, 1H, J = 1.2 Hz), 8.72 (bs, 1H). 13C-NMR (CDCl3, 100 MHz): δ = 21.5, 51.0, 108.2, 111.1, 121.1, 124.8, 126.0, 131.1, 131.6, 134.4, 165.8 ppm. The values are in accordance with the literature [78].

Methyl 5-chloro-1H-indole-3-carboxylate (6i) (309.3 mg, 78%). Off-white solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 4.36 (s, 3H), 7.74 (d, 1H, J = 8.6 Hz), 8.05 (d, 1H, J = 8.6 Hz), 8.55 (s, 1H), 8.69 (s, 1H), 12.65 (s, 1H). 13C-NMR (DMSO-d6, 100 MHz): δ = 51.6, 107.2, 114.8, 120.6, 123.4, 127.1, 127.8, 134.7, 135.9, 165.4. The values are in accordance with the literature [73].

Methyl 5-bromo-1H-indole-3-carboxylate (6j) (820.0 mg, 81%). Off-white solid: 1H-NMR (CDCl3, 400 MHz): δ = 3.90 (s, 3H), 7.28 (d, 1H, J = 8.6 Hz), 7.36 (dd, 1H, J = 8.6 and 1.8 Hz), 7.91 (d, 1H, J = 2.9 Hz), 8.32 (d, 1H, J = 1.8 Hz), 8.61 (bs, 1H). 13C-NMR (CDCl3, 100 MHz): δ = 51.2, 108.8, 112.9, 115.7, 124.3, 126.3, 127.4, 131.7, 134.7, 165.1 ppm. The values are in accordance with the literature [79]. 

Methyl 5-iodo-1H-indole-3-carboxylate (6k) (542.9 mg, 90%). Off-white solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 3.81 (s, 3H), 7.34 (d, 1H, J = 8.5 Hz), 7.48 (dd, 1H, J = 8.5 and 1.5 Hz), 8.09 (d, 1H, J = 2.9 Hz), 8.33 (d, 1H, J = 1.3 Hz), 12.09 (bs, 1H). 13C-NMR (DMSO-d6, 100 MHz): δ = 50.8, 85.7, 105.7, 114.8, 128.1, 128.7, 130.4, 133.2, 135.5, 164.4. ppm. The values are in accordance with the literature [80].

Methyl 5-methoxy-1H-indole-3-carboxylate (6l). (214.2 mg, 52%). Off-white solid: 1H-NMR (CDCl3, 400 MHz): δ = 3.87 (s, 3H), 3.91 (s, 3H), 6.90 (dd, 1H, J = 8.8 and 2.5 Hz), 7.28 (d, 1H, J = 8.8 Hz), 7.66 (d, 1H, J = 2.5 Hz), 7.85 (d, 1H, J = 3.0 Hz), 8.74 (bs, 1H). 13C-NMR (CDCl3, 100 MHz): δ = 51.0, 55.8, 102.8, 108.3, 112.3, 113.7, 126.7, 131.0, 131.2, 155.9, 165.8 ppm. The values are in accordance with the literature [79].

Methyl 5-acetyl-1H-indole-3-carboxylate (6m). (9.083 g, 84%). Off-white solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 2.63 (s, 3H), 3.84 (s, 3H), 7.56 (d, 1H, J = 8.6 Hz), 7.84 (dd, 1H, J = 8.6 and 1.5 Hz), 8.22 (d, 1H, J = 3.0 Hz), 8.65 (d, 1H, J = 1.5 Hz), 12.25 (bs, 1H). 13C-NMR (DMSO-d6, 100 MHz): δ = 26.7, 50.8, 107.7, 112.3, 122.0, 122.5, 125.2, 130.8, 134.2, 138.9, 164.4, 197.4 ppm. HRMS (ESI+) m/z [M + Na]+ calculated for C12H11NO3Na 240.0637, found 240.0634.

Methyl 4-methyl-1H-indole-3-carboxylate (6n; C-4 isomer) (348.7 mg, 46%). Off-white solid: 1H-NMR (CDCl3, 400 MHz): δ = 2.87 (s, 3H), 3.87 (s, 3H), 7.03 (d, 1H, J = 7.1 Hz), 7.15 (t, 1H, J = 7.6 Hz), 7.22 (d, 1H, J = 8.0 Hz), 7.89 (d, 1H, J = 3.0 Hz), 8.76 (bs, 1H). 13C-NMR (CDCl3, 100 MHz): δ = 22.3, 51.1, 109.2, 109.5, 123.4, 124.0, 124.4, 132.1, 132.4, 136.9, 165.4 ppm. The values are in accordance with the literature [81].

Methyl 6-methyl-1H-indole-3-carboxylate (6n; C-6 isomer) (257.7 mg, 34%). Off-white solid: 1H-NMR (CDCl3, 400 MHz): δ = 2.45 (s, 3H), 3.91 (s, 3H), 7.10 (d, 1H, J = 8.0 Hz), 7.18 (s, 1H), 7.83 (d, 1H, J = 3.0 Hz), 8.04 (d, 1H, J = 8.0 Hz), 8.70 (bs, 1H). 13C-NMR (CDCl3, 100 MHz): δ = 21.6, 51.0, 108.5, 111.4, 121.0, 123.6, 123.8, 130.5, 133.1, 136.5, 165.8 ppm. The values are in accordance with the literature [81].

Methyl 4-chloro-1H-indole-3-carboxylate (6o; C-4 isomer) (186.0 mg, 44%). Pale yellow solid: 1H-NMR (DMSO-d6, 400 MHz) δ = 3.76 (s, 3H), 7.13 – 7.26 (m, 2H), 7.46 (dd, 1H, J = 6.7 and 2.3 Hz), 8.13 (d, 1H, J = 2.6 Hz), 12.18 (s, 1H). 13C-NMR (DMSO-d6, 100 MHz) δ = 51.8, 107.8, 112.4, 123.3, 123.6, 124.1, 125.8, 135.0, 139.3, 164.4. HRMS (ESI-) m/z [M − H]− calculated for C10H7NO2Cl 208.0165, found 208.0163.

Methyl 6-chloro-1H-indole-3-carboxylate (6o; C-6 isomer) (175.6 mg, 42%). Pale yellow solid: 1H-NMR (CDCl3, 400 MHz) δ = 3.94 (s, 3H), 7.26 (d, 1H, J = 9.4 Hz), 7.43 (s, 1H), 7.92 (s, 1H), 8.11 (d, 1H, J = 8.6 Hz), 8.60 (s, 1H). 13C-NMR (DMSO-d6, 100 MHz) δ = 52.7, 108.3, 113.8, 123.4, 123.5, 125.9, 129.0, 135.1, 138.4, 166.7. The values are in accordance with the literature [62].

Methyl 4-bromo-1H-indole-3-carboxylate (6p; C-4 isomer) (258.8 mg, 51%). Pale yellow solid: 1H-NMR (DMSO-d6, 400 MHz) δ = 3.77 (s, 3H), 7.11 (t, 1H, J = 7.9 Hz), 7.39 (d, 1H, J = 7.5 Hz), 7.51 (d, 1H, J = 7.8 Hz), 8.12 (s, 1H), 12.16 (s, 1H). 13C-NMR (DMSO-d6, 100 MHz) δ = 51.7, 108.4, 112.9, 113.7, 124.4, 125.0, 127.1, 134.7, 139.0, 164.5. HRMS (ESI+) m/z [M + Na]+ calculated for C10H8NO2BrNa 275.9636, found 275.9642.

Methyl 6-bromo-1H-indole-3-carboxylate (6p; C-6 isomer) (200.1 mg, 39%). Pale yellow solid: 1H-NMR (DMSO-d6, 400 MHz) δ = 3.80 (s, 3H), 7.32 (dd, 1H, J = 8.5 and 1.8 Hz), 7.67 (s, 1H), 7.92 (d, 1H, J = 8.5 Hz), 8.11 (d, 1H, J = 2.8 Hz), 12.03 (s, 1H). 13C-NMR (DMSO-d6, 100 MHz) δ = 51.7, 107.5, 115.9, 115.9, 123, 125.1, 125.6, 134.2, 138.1, 165.3. HRMS (ESI-) m/z [M − H]− calculated for C10H7NO2Br 251.9660, found 251.9657.

Methyl 4-acetyl-1H-indole-3-carboxylate (6q; C-4 isomer) (539.8 mg, 62%). Off-white solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 2.45 (s, 3H), 3.72 (s, 3H), 7.18 (d, 1H, J = 7.2 Hz), 7.26 (t, 1H, J = 7.5 Hz), 7.60 (d, 1H, J = 7.9 Hz), 8.14 (s, 1H), 12.17 (bs, 1H). 13C-NMR (CDCl3, 100 MHz): δ = 31.1, 51.0, 108.2, 114.3, 119.8, 120.7, 122.5, 132.6, 135.3, 137.0, 165.2, 205.2 ppm. HRMS (ESI+) m/z [M + Na]+ calculated for C12H11NO3Na 240.0637, found 240.0634.

Methyl 6-acetyl-1H-indole-3-carboxylate (6q; C-6 isomer) (237.7 mg, 27%). Off-white solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 2.66 (s, 3H), 3.86 (s, 3H), 7.84 (dd, 1H, J = 8.4 and 1.5 Hz), 8.10 (d, 1H, J = 8.4 Hz), 8.15 (d, 1H, J = 1.5 Hz), 8.33 (d, 1H, J = 3.0 Hz), 12.39 (bs, 1H). 13C-NMR (DMSO-d6, 100 MHz): δ = 26.7, 50.8, 106.7, 113.4, 120.1, 121.1, 129.9, 131.5, 135.7, 135.9, 164.4, 197.3 ppm. HRMS (ESI+) m/z [M+Na]+ calculated for C12H11NO3Na 240.0637, found 240.0640.

Methyl 4-methoxy-1H-indole-3-carboxylate (6r; C-4 isomer) (111.8 mg, 27%). Off-white solid: 1H-NMR (CDCl3, 400 MHz): δ = 3.86 (s, 3H), 3.93 (s, 3H), 6.66 (d, 1H, J = 7.8 Hz), 7.00 (d, 1H, J = 8.0 Hz), 7.16 (t, 1H, J = 7.0 Hz), 7.81 (d, 1H, J = 2.8 Hz), 9.11 (bs, 1H). 13C-NMR (CDCl3, 100 MHz): δ = 51.3, 55.9, 102.9, 105.0, 108.6, 115.4, 124.2, 131.3, 138.4, 154.2, 165.0 ppm. HRMS (ESI+) m/z [M + Na]+ calculated for C11H11NO3Na 228.0637, found 228.0634.

Methyl 6-methoxy-1H-indole-3-carboxylate (6r; C-6 isomer) (189.5 mg, 46%). Off-white solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 3.78 (s, 6H), 6.83 (dd, 1H, J = 8.6 and 2.2 Hz), 6.96 (d, 1H, J = 2.2 Hz), 7.84 (d, 1H, J = 8.6 Hz), 7.94 (d, 1H, J = 3.0 Hz), 11.70 (bs, 1H). 13C-NMR (DMSO-d6, 100 MHz): δ = 50.5, 55.2, 95.2, 106.3, 111.3, 119.7, 121.0, 131.2, 137.1, 156.1, 164.7 ppm. The values are in accordance with the literature [82]. 

Methyl 7-methyl-1H-indole-3-carboxylate (6s) (245.9.5 mg, 65%). Off-white solid: 1H-NMR (CDCl3, 400 MHz): δ = 2.50 (s, 3H), 3.92 (s, 3H), 7.06 (d, 1H, J = 7.1 Hz), 7.19 (t, 1H, J = 7.6 Hz), 7.90 (d, 1H, J = 2.8 Hz), 8.02 (d, 1H, J = 8.0 Hz), 8.71 (bs, 1H). 13C-NMR (CDCl3, 100 MHz): δ = 16.5, 51.1, 109.2, 119.2, 120.7, 122.2, 123.8, 125.4, 130.7, 135.7, 165.8 ppm. The values are in accordance with the literature [83].

Methyl 6,7-dimethyl-1H-indole-3-carboxylate (6t) (235.0 mg, 58%). Off-white solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 2.32 (s, 3H), 2.39 (s, 3H), 3.79 (s, 3H), 6.99 (d, 1H, J = 8.0 Hz), 7.71 (d, 1H, J = 8.0 Hz), 7.99 (d, 1H, J = 3.0 Hz), 11.78 (bs, 1H). 13C-NMR (DMSO-d6, 100 MHz): δ = 13.1, 18.9, 50.5, 106.6, 117.4, 119.4, 123.8, 123.9, 129.5, 131.6, 136.5, 164.8 ppm. HRMS (ESI+) m/z [M + Na]+ calculated for C12H13NO2Na 226.0844, found 226.0845.

Methyl 6-chloro-7-methyl-1H-indole-3-carboxylate (6u) (299.8 mg, 67%). Off-white solid: 1H-NMR (CDCl3, 400 MHz): δ = 2.52 (s, 3H), 3.91 (s, 3H), 7.26 (d, 1H, J = 8.6 Hz), 7.90 (d, 1H, J = 2.9 Hz), 7.93 (d, 1H, J = 8.6 Hz), 8.56 (bs, 1H). 13C-NMR (CDCl3, 100 MHz): δ = 13.8, 51.2, 109.6, 118.6, 119.8, 123.5, 124.1, 128.9, 131.0, 136.2, 165.3 ppm. HRMS (ESI-) m/z [M − H]− calculated for C11H9ClNO2 222.0322, found 222.0314.

Methyl 4,6-dimethyl-1H-indole-3-carboxylate (6v) (607.7 mg, 75%). Off-white solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 2.33 (s, 3H), 2.70 (s, 3H), 3.73 (s, 3H), 6.74 (s, 1H), 7.07 (s, 1H), 7.96 (d, 1H, J = 3.0 Hz), 11.71 (bs, 1H). 13C-NMR (DMSO-d6, 100 MHz): δ = 20.9, 21.9, 50.6, 107.2, 109.7, 122.1, 124.9, 130.3, 131.6, 132.7, 137.6, 164.6 ppm. HRMS (ESI-) m/z [M − H]− calculated for C12H12NO2 202.0868, found 202.0872.

Methyl 1,6,7,8-tetrahydrocyclopenta[g]indole-3-carboxylate (6w) (305.6 mg, 71%). Off-white solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 2.08–2.15 (m, 2H), 2.95 (t, 2H, J = 7.3 Hz), 3.04 (t, 2H, J = 7.3 Hz), 3.79 (s, 3H), 7.08 (d, 1H, J = 8.0 Hz), 7.79 (d, 1H, J = 8.0 Hz), 7.99 (d, 1H, J = 3.0 Hz), 11.88 (bs, 1H). 13C-NMR (DMSO-d6, 100 MHz): δ = 25.0, 29.9, 32.6, 50.6, 106.9, 118.1, 118.5, 124.4, 126.5, 131.6, 133.5, 138.3, 164.9 ppm. HRMS (ESI+) m/z [M + Na]+ calculated for C13H13NO2Na 238.0844, found 238.0848.

Methyl 7-chloro-1H-indole-3-carboxylate (6x) (175.7 mg, 21%). Pale yellow solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 3.82 (s, 3H), 7.18 (t, 1H, J = 7.8 Hz), 7.29 (dd, 1H, J = 7.7 and 1.1 Hz), 7.98 (d, 1H, J = 7.9 Hz), 8.11 (d, 1H, J = 3.1 Hz), 12.36 (s, 1H). 13C-NMR (DMSO-d6, 100 MHz) δ = 51.7, 108.6, 117.6, 120.4, 122.9, 123.3, 128.4, 134.1, 134.2, 165.3. HRMS (ESI-) m/z [M − H]− calculated for C10H7NO2Cl 208.0165, found 208.0158.

Methyl 7-fluoro-1H-indole-3-carboxylate (6y) (285.6 mg, 37%). Off-white solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 3.81 (s, 3H), 7.05 (dd, 1H, J = 11.5 and 8.0 Hz), 7.13–7.18 (m, 1H), 7.81 (d, 1H, J = 8.0 Hz), 8.12 (s, 1H), 12.49 (bs, 1H). 13C-NMR (DMSO-d6, 100 MHz): δ = 50.8, 107.3 (d, J = 16 Hz), 107.4, 116.5 (d, J = 3.5 Hz), 121.8 (d, J = 6.3 Hz), 124.2 (d, J = 13.5 Hz), 129.3 (d, J = 5.3 Hz), 133.1, 149.2 (d, J = 244 Hz), 164.4 ppm. HRMS (ESI-) m/z [M − H]− calculated for C10H7FNO2 192.0461, found 192.0457.

Methyl 7-methoxy-1H-indole-3-carboxylate (6z) (90.4 mg, 11%). Off-white solid: 1H-NMR (CDCl3, 500 MHz): δ = 3.91 (s, 3H), 3.94 (s, 3H), 6.70 (d, 1H, J = 7.8 Hz), 7.17 (t, 1H, J = 8.0 Hz), 7.75 (d, 1H, J = 8.0 Hz), 7.87 (d, 1H, J = 3.0 Hz), 8.90 (bs, 1H). 13C-NMR (CDCl3, 125 MHz): δ = 51.0, 55.4, 102.9, 109.2, 113.9, 122.5, 126.7, 127.1, 130.3, 146.1, 165.7 ppm. The values are in accordance with the literature [84].

Methyl 7-chloro-4-fluoro-1H-indole-3-carboxylate (6aa) (245.2 mg, 27%). Off-white solid: 1H-NMR (CDCl3, 400 MHz): δ = 3.90 (s, 3H), 6.87 (dd, 1H, J = 10.5 and 8.5 Hz), 7.16 (dd, 1H, J = 8.5 and 3.6 Hz), 7.96 (d, 1H, J = 3.0 Hz), 9.13 (bs, 1H). 13C-NMR (CDCl3, 100 MHz): δ = 51.8, 108.8 (d, J = 23 Hz), 109.4 (d, J = 3.5 Hz), 112.1 (d, J = 4.1 Hz), 115.1 (d, J = 22 Hz), 123.0 (d, J = 8.0 Hz), 132.2, 135.6 (d, J = 10.0 Hz), 155.1 (d, J = 253 Hz), 164.0 ppm. HRMS (ESI+) m/z [M + Na]+ calculated for C10H7ClFNO2Na 250.0047, found 250.0051.

Methyl 4,7-dibromo-1H-indole-3-carboxylate (6ab) (598.0 mg, 45%). Off-white solid: 1H-NMR (DMSO-d6, 500 MHz): δ = 3.78 (s, 3H), 7.33 (d, 1H, J = 8.0 Hz), 7.37 (d, 1H, J = 8.0 Hz), 8.09 (d, 1H, J = 3.1 Hz), 12.40 (bs, 1H). 13C-NMR (DMSO-d6, 125 MHz): δ = 51.1, 104.6, 109.1, 112.3, 125.3, 126.1, 127.3, 134.3, 136.0, 163.3 ppm. HRMS (ESI+) m/z [M + Na]+ calculated for C10H7Br2NO2Na 357.8700, found 357.8698.

Methyl 1H-benzo[g]indole-3-carboxylate (6ac) (745.8 mg, 83%). Yellow-brown solid: 1H-NMR (DMSO-d6, 400 MHz): δ = 3.85 (s, 3H), 7.48 (t, 1H, J = 7.5 Hz), 7.60 (t, 1H, J = 7.5 Hz), 7.65 (d, 1H, J = 8.7 Hz), 7.97 (d, 1H, J = 8.2 Hz), 8.10–8.19 (m, 2H), 8.44 (d, 1H, J = 8.2 Hz), 12.84 (s, 1H). 13C-NMR (DMSO-d6, 100 MHz): δ = 51.6, 109.1, 121.0, 121.6, 122.8, 122.9, 122.9, 125.3, 126.8, 129.3, 130.9, 130.9, 132.1, 165.8. The values are in accordance with the literature [85].

(6-Methoxy-1H-indol-3-yl)(3,4,5-trimethoxyphenyl)methanone (6ad; C-6 isomer) (257.3 mg, 30%). Off-white solid: 1H-NMR (CDCl3, 500 MHz): δ = 3.79 (s, 3H), 3.83 (s, 6H), 3.91 (s, 3H), 6.87 (d, 1H, J = 2.2 Hz), 6.93 (dd, 1H, J = 8.7 and 2.2 Hz), 7.07 (s, 2H), 7.59 (d, 1H, J = 3.0 Hz), 8.21 (d, 1H, J = 8.7 Hz), 9.48 (bs, 1H). 13C-NMR (CDCl3, 125 MHz): δ = 55.5, 56.2 (2C), 60.9, 95.1, 106.4 (2C), 112.2, 116.7, 120.4, 122.9, 132.9, 135.9, 137.5, 140.9, 152.9 (2C), 157.5, 190.6 ppm. The values are in accordance with the literature [20].

(4-Methoxy-1H-indol-3-yl)(3,4,5-trimethoxyphenyl)methanone (6ad; C-4 isomer) (212.1 mg, 25%). Off-white solid: 1H-NMR (DMSO-d6, 500 MHz): δ = 3.65 (s, 3H), 3.75 (s, 3H), 3.77 (s, 6H), 6.63 (d, 1H, J = 7.8 Hz), 7.09 (s, 2H), 7.10 (d, 1H, J = 7.8 Hz), 7.16 (t, 1H, J = 7.9 Hz), 7.75 (d, 1H, J = 3.0 Hz), 11.86 (bs, 1H). 13C-NMR (DMSO-d6, 125 MHz): δ = 55.0, 55.9 (2C), 60.1, 101.9, 105.2, 107.0 (2C), 115.7, 115.9, 123.7, 131.6, 135.3, 138.2, 140.7, 152.3 (2C), 153.6, 188.3 ppm. The values are in accordance with the literature [20].

(±)-Methyl (2R,3R,3aS)-2-hydroxy-3a-methyl-3,3a-dihydro-2H-indole-3-carboxylate (10s) (144.1 mg, 21%). Off-white solid: 1H-NMR (CDCl3, 400 MHz): δ = 1.00 (s, 3H), 2.95 (d, 1H, J = 7.4 Hz), 3.79 (s, 3H), 5.7 (bs, 1H), 5.89 (d, 1H, J = 7.4 Hz), 6.09–6.13 (m, 1H), 6.44–6.47 (m, 2H), 6.58–6.62 (m, 1H). 13C-NMR (CDCl3, 100 MHz): δ = 20.0, 52.1, 53.3, 61.8, 91.0, 120.7, 121.3, 136.0, 140.4, 170.5, 178.3 ppm. HRMS (ESI+) m/z [M + Na]+ calculated for C11H13NO3Na 230.0793, found 230.0785.

(±)-(2R,3R,3aR)-Methyl 2-hydroxy-3a,4-dimethyl-3,3a-dihydro-2H-indole-3-carboxylate (10t) (150.6 mg, 34%). Off-white solid: 1H-NMR (CDCl3, 500 MHz): δ = 1.13 (s, 3H), 1.91 (s, 3H), 2.91 (d, 1H, J = 7.4 Hz), 3.77 (s, 3H), 5.4 (bs, 1H), 5.80 (d, 1H, J = 6.0 Hz), 5.85 (d, 1H, J = 7.4 Hz), 6.27 (d, 1H, J = 9.7 Hz), 6.50 (dd, 1H, J = 9.7 and 6.0 Hz). 13C-NMR (CDCl3, 125 MHz): δ = 15.4, 20.1, 52.0, 57.9, 60.5, 94.1, 118.4, 118.6, 136.5, 150.3, 171.6, 179.3 ppm. HRMS (ESI+) m/z [M + Na]+ calculated for C12H15NO3Na 244.0950, found 244.0952.

(±)-(2R,3R,3aS)-Methyl 4-chloro-2-hydroxy-3a-methyl-3,3a-dihydro-2H-indole-3-carboxylate (10u) (128.8 mg, 27%). Off-white solid: 1H-NMR (CDCl3, 500 MHz): δ = 1.30 (s, 3H), 3.02 (d, 1H, J = 7.5 Hz), 3.77 (s, 3H), 5.7 (bs, 1H), 5.75 (d, 1H, J = 7.5 Hz), 6.16 (d, 1H, J = 6.3 Hz), 6.42 (d, 1H, J = 9.6 Hz), 6.55 (dd, 1H, J = 9.6 and 6.3 Hz). 13C-NMR (CDCl3, 125 MHz): δ = 19.8, 52.2, 59.9, 61.0, 93.8, 119.5, 120.4, 135.5, 144.5, 170.8, 177.5 ppm. HRMS (ESI+) m/z [M + Na]+ calculated for C11H12ClNO3 264.0403, found 264.0404.

The relative stereochemistry was assigned based on the 1HNMR, COSY, HSQC and NOESY experiments. The syn relationship between H(2) and H(3) was assigned based on the observed 3J(H,H) = 7.5 Hz and their NOE interactions. The syn relationship between Me(3a) and H(3) was assigned based on their NOE interactions.

(±)-Methyl (2R,3R,3aR)-2-hydroxy-3a-methoxy-3,3a-dihydro-2H-indole-3-carboxylate (10z) (195.8 mg, 22%). Off-white solid: 1H-NMR (CDCl3, 500 MHz): δ = 2.87 (d, 1H, J = 6.1 Hz), 3.03 (s, 3H), 3.79 (s, 3H), 3.9 (bs, 1H), 6.21 (d, 1H, J = 6.1 Hz), 6.43 (d, 1H, J = 9.6 Hz), 6.51 (ddd, 1H, J = 9.6, 5.5 and 1.0 Hz), 6.58–6.62 (m, 2H), 6.67 (d, 1H, J = 9.6 Hz). 13C-NMR (CDCl3, 125 MHz): δ = 52.2, 52.4, 65.4, 81.4, 91.8, 123.3, 127.4, 131.4, 134.4, 168.6, 172.3 ppm. HRMS (ESI+) m/z [M + Na]+ calculated for C11H13NO4Na 246.0742, found 246.0735.

4. Conclusions
In summary, we reported a practical (scalable) and instrumentally simple methodology to synthesize N-unprotected polysubstituted indoles endowed with an electron-withdrawing group at C-3 position. The importance of these N-unprotected heterocycles in organic synthesis (molecular platforms), asymmetric catalysis (chiral catalysts), medicinal chemistry (therapeutics) and materials sciences (molecular devices) ensures the practical use of this methodology in different fields of organic chemistry. Studies aimed at the use of these 3-EWG-indoles as molecular platforms for catalytic asymmetric dearomatization and their therapeutic/biological annotations are in progress in our lab.

Acknowledgments
Authors thank La Laguna University for the use of SEGAI. 

Sample Availability: Samples of the compounds 6a–ad are available from the authors.

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Materials
1H and 13C-NMR spectra for compounds 6 and 10 are available online.

Click here for additional data file.

 Author Contributions
R.D.-R. and D.T. conducted experimental work; D.T. and F.G.-T. initiated the project, designed experiments and wrote the paper. All authors have read and agreed to the published version of the manuscript.

Funding
This research was funded by the Spanish Ministry of Science, Innovation and Universities (MICINN), State Research Agency (AEI) and the European Regional Development Funds (ERDF) (PGC2018-094503-B-C21). 

Conflicts of Interest
The authors declare no conflict of interest. 

Schemes and Table
molecules-25-05595-sch001_Scheme 1Scheme 1 Strategy for the synthesis of indoles 6 with electron-withdrawing group at the C-3 position (3-EWG indoles). (a) General [3,3] sigmatropic disconnection. (b) Zn/Au- catalyzed synthesis of indoles. (c) This work: consecutive two-step reaction manifold.

molecules-25-05595-sch002_Scheme 2Scheme 2 DABCO-catalyzed reaction of N-Benzoyl-N-phenylhydroxylamine (4a-N-Bz) and methyl propiolate (5a).

molecules-25-05595-sch003_Scheme 3Scheme 3 Coupling reduction and cascade condensation/rearrangement/elimination reactions in a consecutive 2-step protocol.

molecules-25-05595-sch004_Scheme 4Scheme 4 Alkyne scope of the protocol. Reaction conditions: N-phenylhydroxylamine (4a) (4.0 mmol), alkyne 5 (4.2 mmol), DABCO (5 mol%), CH2Cl2 (20 mL), 0 °C to RT, 1 h. a Overnight.

molecules-25-05595-sch005_Scheme 5Scheme 5 Nitroarene scope of the protocol. Reaction conditions: 1) nitroarene 3 (4 mmol), NH2NH2.H2O (4.4 mmol), Rh/C (5%) (20 mg), THF (20 mL), 0 °C to RT, 3 h, filtration on celite plug and concentration; 2) methyl propiolate (5a) (4.2 mmol), DABCO (5 mol%), CH2Cl2 (20 mL), 0 °C to RT, 1 h. a50 mmol scale. b10s (21%). c10t (34%). d10u (27%). e10z (22%) (See Scheme 6 for structures).

molecules-25-05595-sch006_Scheme 6Scheme 6 Alternative [3,3]-sigmatropic rearrangement outcome of ortho-substituted N-oxyenamines.

molecules-25-05595-t001_Table 1Table 1 Optimization of the reaction conditions.

entry	DBACO	Temperature	Time	Yield (6a)	
1	10 mol%	RT	1 h	68%	
2	10 mol%	0 °C to RT	1 h	83%	
3	1 mol%	0 °C to RT	Overnight	75%	

4
	
5 mol%
	
0 °C to RT
	
1 h
	
82%
	
5	5 mol%	−25 °C to RT	2 h	86%	
Red: To highlight that these are the best conditions.
==== Refs
References and Note
1. Barluenga J.  Valdés C.   Five-membered heterocycles: Indole and related systems Modern Heterocyclic Chemistry Alvarez-Builla J.  Vaquero J.J.  Barluenga J.   Wiley-VCH Verlag GmbH & Co. Weinheim, Germany 2011 377 531 
2. Dhuguru J.  Skouta R.   Role of indole scafolds as pharmacophores in the development of anti-lung cancer agents Molecules 2020 25 1615 10.3390/molecules25071615 
3. Wan Y.  Li Y.  Yan C.  Yan M.  Tang Z.   Indole: A privileged scaffold for the design of anti-cancer agents Eur. J. Med. Chem. 2019 183 111691 111709 10.1016/j.ejmech.2019.111691 31536895 
4. Goyal D.  Kaur A.  Goyal B.   Benzofuran and indole: Promising scaffolds for drug development in Alzheimer’s disease ChemMedChem 2018 13 1275 1299 10.1002/cmdc.201800156 29742314 
5. Chadha N.  Silakari O.   Indoles as therapeutics of interest in medicinal chemistry: Bird’s eye view Eur. J. Med. Chem. 2017 134 159 184 10.1016/j.ejmech.2017.04.003 28412530 
6. Gribble G.W.   Indole Ring Synthesis: From Natural Products to Drug Discovery John Wiley & Sons Chichester, UK 2016 
7. Owczarczyk Z.R.  Braunecker W.A.  Garcia A.  Larsen R.  Nardes A.M.  Kopidakis N.  Ginley D.S.  Olson D.C.   5,10-Dihydroindolo[3,2-b]indole-based copolymers with alternating donor and acceptor moieties for organic photovoltaics Macromolecules 2013 46 1350 1360 10.1021/ma301987p 
8. Nie G.M.  Bai Z.M.  Yu W.Y.  Zhang L.   Electrochemiluminescence biosensor for ramos cells based on a nanostructured conducting polymer composite material (PICA-MWNTs) J. Polym. Sci. Part A Polym. Chem. 2013 51 2385 2392 10.1002/pola.26623 
9. Manickam M.  Iqbal P.  Belloni M.  Kumar S.  Preece J.A.   A brief review of carbazole-based photorefractive liquid crystalline materials Isr. J. Chem. 2012 52 917 934 10.1002/ijch.201200058 
10. Li T.Z.  Liu S.J.  Tan W.  Shi F.   For a recent review on the current state of the field, see: Catalytic asymmetric construction of axially chiral indole-based frameworks: An emerging area Chem. Eur. J. 2020 26 10.1002/chem.202001397 
11. Zhang Y.C.  Jiang F.  Shi F.   Organocatalytic asymmetric synthesis of indole-based chiral heterocycles: Strategies, reactions, and outreach Acc. Chem. Res. 2020 53 425 446 10.1021/acs.accounts.9b00549 31820922 
12. Ma C.  Sheng F.T.  Wang H.Q.  Deng S.  Zhang Y.C.  Jiao Y.  Tan W.  Shi F.   Atroposelective access to oxindole-based axially chiral styrenes via the strategy of catalytic kinetic resolution J. Am. Chem. Soc. 2020 142 15686 15696 10.1021/jacs.0c00208 32845127 
13. Lai Y.T.  Wang T.  O’Dell S.  Louder M.K.  Schön A.  Cheung C.S.  Chuang G.Y.  Druz A.  Lin B.  McKee K.    Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry Nat. Commun. 2019 10 47 58 10.1038/s41467-018-07851-1 30604750 
14. Liu T.  Huang B.  Zhan P.  De Clercq E.  Liu X.   Discovery of small molecular inhibitors targeting HIV-1 gp120eCD4 interaction drived from BMS-378806 J. Eur. Med. Chem. 2014 86 481 490 10.1016/j.ejmech.2014.09.012 25203778 
15. Lei H.  Guo M.  Li X.  Jia F.  Li C.  Yang Y.  Cao M.  Jiang N.  Ma E.  Zhai X.    Discovery of novel indole-based allosteric highly potent ATX inhibitors with great in vivo efficacy in a mouse lung fibrosis model J. Med. Chem. 2020 63 7326 7346 10.1021/acs.jmedchem.0c00506 32479084 
16. Apirakkan O.  Gavrilović I.  Cowan D.A.  Abbate V.   In vitro phase i metabolic profiling of the synthetic cannabinoids AM-694, 5F-NNEI, FUB-APINACA, MFUBINAC, and AMB-FUBINACA Chem. Res. Toxicol. 2020 33 1653 1664 10.1021/acs.chemrestox.9b00466 32301604 
17. Liou J.P.   3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity J. Med. Chem. 2017 125 1268 1278 
18. Smith A.C.  Kung D.W.  Shavnya A.  Brandt T.A.  Dent P.D.  Genung N.E.  Cabral S.  Panteleev J.  Herr M.  Yip K.N.    Evolution of the synthesis of AMPK activators for the treatment of diabetic nephropathy: From three preclinical candidates to the investigational new drug PF-06409577 Org. Process. Res. Dev. 2018 22 681 696 10.1021/acs.oprd.8b00059 
19. Wu Y.S.  Coumar M.S.  Chang J.Y.  Sun H.Y.  Kuo F.M.  Kuo C.C.  Chen Y.J.  Chang C.Y.  Hsiao C.L.  Liou J.P.    Synthesis and evaluation of 3-aroylindoles as anticancer agents: Metabolite approach J. Med. Chem. 2009 52 4941 4945 10.1021/jm900060s 19586033 
20. Liou J.P.  Chang Y.L.  Kuo F.M.  Chang C.W.  Tseng H.Y.  Wang C.C.  Yang Y.N.  Chang J.Y.  Lee S.J.  Hsieh H.P.    Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents J. Med. Chem. 2004 47 4247 4257 10.1021/jm049802l 15293996 
21. Kuo C.C.  Hsieh H.P.  Pan W.Y.  Chen C.P.  Liou J.P.  Lee S.J.  Chang Y.L.  Chen L.T.  Chen C.T.  Chang J.Y.    BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo Cancer Res. 2004 64 4621 4628 10.1158/0008-5472.CAN-03-3474 15231674 
22. Huck C.J.  Sarlah D.   Shaping Molecular Landscapes: Recent Advances, Opportunities, and Challenges in Dearomatization Chem 2020 6 1589 1603 10.1016/j.chempr.2020.06.015 32715154 
23. Li K.  Gonçalves T.P.  Huang K.W.  Lu Y.   Dearomatization of 3-nitroindoles by a phosphine-catalyzed enantioselective [3 + 2] annulation reaction Angew. Chem. Int. Ed. 2019 58 5427 5431 10.1002/anie.201900248 30770616 
24. Wang H.  Zhang J.  Tu Y.  Zhang J.   Phosphine-catalyzed enantioselective dearomative [3 + 2]-cycloaddition of 3-nitroindoles and 2-nitrobenzofurans Angew. Chem. Int. Ed. 2019 58 5422 5426 10.1002/anie.201900036 30860302 
25. Suo J.J.  Liu W.  Du J.  Ding C.H.  Hou X.L.   Diastereo-and enantioselective palladium-catalyzed dearomative [3 + 2] cycloaddition of 3-nitroindoles Chem. Asian J. 2018 13 959 963 10.1002/asia.201800133 29570935 
26. Cheng Q.  Zhang F.  Cai Y.  Guo Y.L.  You S.L.   Stereodivergent synthesis of tetrahydrofuroindoles through Pd-catalyzed asymmetric dearomative formal [3 + 2] cycloaddition Angew. Chem. Int. Ed. 2018 57 2134 2138 10.1002/anie.201711873 29330914 
27. Sun M.  Zhu Z.Q.  Gu L.  Wan X.  Mei G.J.  Shi F.   Catalytic asymmetric dearomative [3 + 2] cycloaddition of electron-deficient indoles with all-carbon 1,3-dipoles J. Org. Chem. 2018 83 2341 2348 10.1021/acs.joc.7b03259 29363965 
28. Zhang J.Q.  Tong F.  Sun B.B.  Fan W.T.  Chen J.B.  Hu D.  Wang X.W.   Pd-catalyzed asymmetric dearomative cycloaddition for construction of optically active pyrroloindoline and cyclopentaindoline derivatives: Access to 3a-aminopyrroloindolines J. Org. Chem. 2018 83 2882 2891 10.1021/acs.joc.8b00046 29457891 
29. Yue D.F.  Zhao J.Q.  Chen X.Z.  Zhou Y.  Zhang X.M.  Xu X.Y.  Yuan W.C.   Multiple hydrogen-bonding bifunctional thiourea-catalyzed asymmetric dearomative [4 + 2] annulation of 3-nitroindoles: Highly enantioselective access to hydrocarbazole skeletons Org. Lett. 2017 19 4508 4511 10.1021/acs.orglett.7b02068 28809570 
30. Gerten L.  Stanley L.M.   Enantioselective dearomative [3 + 2] cycloadditions of indoles with azomethine ylides derived from alanine imino esters Org. Chem. Front. 2016 3 339 343 10.1039/C5QO00346F 
31. Zhao J.Q.  Wu Z.J.  Zhou M.Q.  Xu X.Y.  Zhang X.M.  Yuan W.C.   Zn-catalyzed diastereo-and enantioselective cascade reaction of 3-isothiocyanato oxindoles and 3-nitroindoles: Stereocontrolled syntheses of polycyclic spirooxindoles Org. Lett. 2015 17 5020 5023 10.1021/acs.orglett.5b02489 26412346 
32. Awata A.  Arai T.   PyBidine/Copper catalyst: Asymmetric exo’-selective [3 + 2] cycloaddition using imino ester and electrophilic indole Angew. Chem. Int. Ed. 2014 53 10462 10465 10.1002/anie.201405223 
33. Li Y.  Tur F.  Nielsen R.P.  Jiang H.  Jensen F.  Jørgensen K.A.   Enantioselective formal [4 + 2] cycloadditions to 3-nitroindoles by trienamine catalysis: Synthesis of chiral dihydrocarbazoles Angew. Chem. Int. Ed. 2016 55 1020 1024 10.1002/anie.201509693 26636665 
34. Roche S.P.  Tendoung J.J.Y.  Treguier B.   Advances in dearomatization strategies of indoles Tetrahedron 2015 71 3549 3591 10.1016/j.tet.2014.06.054 
35. Kumar N.  Parle A.   3-Substituted indole: A review Int. J. Chem. Stud. 2019 72 848 856 
36. Norwood V.M.  Huigens R.W.   Harnessing the chemistry of the indole heterocycle to drive discoveries in biology and medicine ChemBioChem 2019 20 2273 2297 10.1002/cbic.201800768 30609199 
37. Joule J.A.   Indole and its derivatives. Chapter 10.13 Science of Synthesis: Houben-Weyl Methods of Molecular Transformations Thomas E.J.   George Thieme Verlag Stuttgart, Germany 2000 Volume 10 361 652 
38. Li L.H.  Niu Z.J.  Liang Y.M.   New Friedel–Crafts strategy for preparing 3-acylindoles Org. Biomol. Chem. 2018 16 7792 7796 10.1039/C8OB02094A 30325392 
39. Wu W.  Su W.   Mild and selective Ru-catalyzed formylation and Fe-catalyzed acylation of free (NH) indoles using anilines as the carbonyl source J. Am. Chem. Soc. 2011 133 11924 11927 10.1021/ja2048495 21755969 
40. Guchhait S.K.  Kashyap M.  Kamble H.   ZrCl4 -Mediated regio-and chemoselective friedel–crafts acylation of indole J. Org. Chem. 2011 76 4753 4758 10.1021/jo200561f 21526849 
41. Katritzky R.  Suzuki K.  Singh S.K.  He H.Y.   Regiospecific C-acylation of pyrroles and indoles using N-acylbenzotriazoles J. Org. Chem. 2003 58 5720 5723 10.1021/jo034187z 
42. Okauchi T.  Itonaga M.  Minami T.  Owa T.  Kitoh K.  Yoshino H.   A general method for acylation of indoles at the 3-position with acyl chlorides in the presence of dialkylaluminum chloride Org. Lett. 2000 2 1485 1487 10.1021/ol005841p 10814479 
43. Zhang W.  Tang J.  Yu W.  Huang Q.  Fu Y.  Kuang G.  Pan C.  Yu G.   Visible light-driven C-3 functionalization of indoles over conjugated microporous polymers ACS Catal. 2018 8 8084 8091 10.1021/acscatal.8b01478 
44. Wu C.J.  Meng Q.Y.  Lei T.  Zhong J.J.  Liu W.Q.  Zhao L.M.  Li Z.J.  Chen B.  Tung C.H.  Wu L.Z.    An oxidant-free strategy for indole synthesis via intramolecular C−C bond construction under visible light irradiation: Cross-coupling hydrogen evolution reaction ACS Catal. 2016 6 4635 4639 10.1021/acscatal.6b00917 
45. Li X.  Gu X.  Li Y.  Li P.   Aerobic transition-metal-free visible-light photoredox indole C-3 formylation reaction ACS Catal. 2014 4 1897 1900 10.1021/cs5005129 
46. Zhang P.  Xiao T.  Xiong S.  Dong X.  Zhou L.   Synthesis of 3-acylindoles by visible-light induced intramolecular oxidative cyclization of o-alkynylated N,N -dialkylamines Org. Lett. 2014 16 3264 3267 10.1021/ol501276j 24895026 
47. Humphrey G.R.  Kuethe J.T.   Practical methodologies for the synthesis of indoles Chem. Rev. 2006 106 2875 2911 10.1021/cr0505270 16836303 
48. Neto J.S.S.  Zeni G.   Recent advances in the synthesis of indoles from alkynes and nitrogen sources Org. Chem. Front. 2020 7 155 210 10.1039/C9QO01315F 
49. Inman M.  Moody C.J.   Indole synthesis-something old, something new Chem. Sci. 2013 4 29 41 10.1039/C2SC21185H 
50. Tabolin A.A.  Ioffe S.L.   Rearrangement of N -oxyenamines and related reactions Chem. Rev. 2014 114 5426 5476 10.1021/cr400196x 24628517 
51. Heravi M.M.  Rohani S.  Zadsirjan V.  Zahedi N.   Fischer indole synthesis applied to the total synthesis of natural products RSC Adv. 2017 7 52852 52887 10.1039/C7RA10716A 
52. Hughes D.L.   Progress in the Fischer indole reaction. A review Org. Prep. Proced. Int. 1993 25 607 632 10.1080/00304949309356257 
53. Bartoli G.  Dalpozzo R.  Nardib M.   Applications of Bartoli indole synthesis Chem. Soc. Rev. 2014 43 4728 4750 10.1039/C4CS00045E 24718836 
54. Dalpozzo R.  Bartoli G.   Bartoli indole synthesis Curr. Org. Chem. 2005 9 163 178 10.2174/1385272053369204 
55. Fischer E.E.  Jourdan F.   Ueber die hydrazine der brenztraubensäure Eur. J. Inorg. Chem. 1883 16 2241 2245 10.1002/cber.188301602141 
56. Wang Y.  Liu L.  Zhang L.   Combining Zn ion catalysis with homogeneous gold catalysis: An efficient annulation approach to N-protected indoles Chem. Sci. 2013 4 739 746 10.1039/C2SC21333H 24244841 
57. Yuan H.  Guo L.  Liu F.  Miao Z.  Feng L.  Gao H.   A copper-catalyzed synthesis of polysubstituted indoles using N -arylhydroxylamines and vinyliodonium salts using the same disconnection pattern has been recently described, although its application to 3-EWG-indoles was not reported. Copper-catalyzed tandem o-vinylation of arylhydroxylamines/[3,3]-rearrangement/cyclization: Synthesis of highly substituted indoles and benzoindoles ACS Catal. 2019 9 3906 3912 
58. Tejedor D.  Delgado-Hernández S.  Colella L.  García-Tellado F.   Catalytic hydrocyanation of activated terminal alkynes Chem. Eur. J. 2019 25 15046 15049 10.1002/chem.201903402 31553088 
59. Tejedor D.  Álvarez-Méndez S.J.  López-Soria J.M.  Martín V.S.  García-Tellado F.   A robust and general protocol for the Lewis-base-catalysed reaction of alcohols and alkyl propiolates Eur. J. Org. Chem. 2014 198 205 10.1002/ejoc.201301303 
60. Mola L.  Font J.  Bosch L.  Caner J.  Costa A.M.  Etxebarría-Jardí G.  Pineda O.  De Vicente D.  Vilarrasa J.   Nucleophile-catalyzed additions to activated triple bonds. Protection of lactams, imides, and nucleosides with MocVinyl and related groups J. Org. Chem. 2013 78 5832 5842 10.1021/jo4006409 23713491 
61. Tejedor D.  Santos-Expósito A.  Méndez-Abt G.  Ruiz-Pérez C.  García-Tellado F.   Trialkylamine versus trialkylphosphine: Catalytic conjugate addition of alcohols to alkyl propiolates Synlett 2009 1223 1226 10.1055/s-0028-1216727 
62. Feierfeil J.  Magauer T.   De novo synthesis of benzannelated heterocycles Chem. Eur. J. 2018 24 1455 1458 10.1002/chem.201705662 29194822 
63. Pereira M.M.A.  Prabhakar S.  Lobo A.M.   A Synthesis of the amaryllidaceae alkaloid pratosine J. Nat. Prod. 1996 59 744 747 10.1021/np9601869 8792621 
64. Hwu J.R.  Patel H.V.  Lin R.J.  Gray M.O.   Novel methods for the synthesis of functionalized indoles from arylhydroxylamines and activated acetylenes J. Org. Chem. 1994 59 1577 1582 10.1021/jo00085a053 
65. Toyota M.  Fukumoto K.   Tandem Michael addition-[3,3]sigmatropic rearrangement processes. Part 2. Construction of cyclopropa[3,4]pyrrolo [3,2-e]indol-4-one (CPI) unit of antitumour antibiotic CC-1065 J. Chem. Soc. Perkin Trans. 1992 1 547 552 10.1039/P19920000547 
66. Blechert S.   Hetero-Cope-rearrangements, region-controlled synthesis of indoles Helv. Chim. Acta 1985 68 1835 1843 10.1002/hlca.19850680705 
67. Chehardoli G.  Bahmani A.   Synthetic strategies, SAR studies, and computer modeling of indole 2 and 3-carboxamides as the strong enzyme inhibitors: A review Mol. Divers. 2020 1 16 10.1007/s11030-020-10061-x 
68. Grandberg I.  Belyaeva L.D.  Dmitriev L.B.   Ratio of indole isomers formed during the fischer cyclization of meta-substituted diethyl ketone phenylhydrazones Chem. Het. Compd. 1971 7 1131 10.1007/BF00510019 
69. Krenske E.H.  Burns J.M.  McGeary R.P.   Claisen rearrangements of benzyl vinyl ethers: Theoretical investigation of mechanism, substituent effects, and regioselectivity Org. Biomol. Chem. 2017 15 7887 7893 10.1039/C7OB01666B 28891574 
70. An ortho-methyl group dropped the yield of the reaction to 25%.


71. Lee K.N.  Lei Z.  Morales-Rivera C.A.  Liu P.  Ngai M.Y.   Mechanistic studies on intramolecular C–H trifluoromethoxylation of (hetero)arenes via OCF3 -migration Org. Biomol. Chem. 2016 14 5599 10.1039/C6OB00132G 27043815 
72. Yang Q.Q.  Marchini M.  Xiao W.J.  Ceroni P.  Bandini M.   Visible-light-induced direct photocatalytic carboxylation of indoles with CBr4 /MeOH Chem. Eur. J. 2015 50 18052 18056 10.1002/chem.201503787 
73. Abe T.  Yamada K.   Amination/cyclization cascade by acid-catalyzed activation of indolenine for the one-pot synthesis of phaitanthrin E Org. Lett. 2016 18 6504 6507 10.1021/acs.orglett.6b03466 27978673 
74. Yu J.  Zhang C.  Yang X.  Su W.   Decarboxylative acylation of N-free indoles enabled by a catalytic amount of copper catalyst and liquid-assisted grinding Org. Biomol. Chem. 2019 17 4446 4451 10.1039/C9OB00622B 30985843 
75. Wynne J.H.  Lloyd C.T.  Jensen S.D.  Boson S.  Stalick W.M.   3-Acylindoles via a one-pot, regioselective Friedel-Crafts reaction Synthesis 2004 2277 2282 10.1002/chin.200507103 
76. Peng J.  Liu L.  Hu Z.  Huang J.  Zhu Q.   Direct carboxamidation of indoles by palladium-catalyzed C–H activation and isocyanide insertion Chem. Commun. 2012 48 3772 3774 10.1039/c2cc30351e 22430019 
77. Velavan A.  Sumathi S.  Balasubramanian K.K.   AlMe3 -mediated region- and chemoselective reactions of indole with carbamoyl electrophiles Eur. J. Org. Chem. 2013 3148 3157 10.1002/ejoc.201300085 
78. Yamazaki K.  Nakamura Y.  Kondo Y.   Solid-phase synthesis of indolecarboxylates using palladium-catalyzed reactions J. Org. Chem. 2003 68 6011 6019 10.1021/jo0340307 12868941 
79. Linton E.C.  Kozlowski M.C.   Catalytic enantioselective Meerwein−Eschenmoser Claisen rearrangement: Asymmetric synthesis of allyl oxindoles J. Am. Chem. Soc. 2008 130 16162 16163 10.1021/ja807026z 18998679 
80. Fisher M.J.  McMurray L.  Lu S.  Morse C.L.  Liow J.S.  Zoghbi S.S.  Kowalski A.  Tye G.L.  Innis R.B.  Aigbirhio F.I.    [Carboxyl-11 C]labelling of four high-affinity cPLA2α inhibitors and their evaluation as radioligands in mice by positron emission tomography ChemMedChem 2018 13 138 146 10.1002/cmdc.201700697 29232493 
81. Natarajan R.  Rappa J.P.  Unnikrishnan P.A.  Radhaman S.  Prathapan S.   A new method for the synthesis of 3-substituted indoles Synlett 2015 26 2467 2471 
82. Zhang Z.W.  Xue H.  Li H.  Kang H.  Feng J.  Lin A.  Liu S.   Collective synthesis of 3-acylindoles, indole-3-carboxylic esters, indole-3-sulfinic acids, and 3-(methylsulfonyl)indoles from free (N-H) indoles via common N-indolyl triethylborate Org. Lett. 2016 18 3918 3921 10.1021/acs.orglett.6b01970 27457258 
83. Ji X.  Huang H.  Wu W.  Li X.  Jiang H.   Palladium-catalyzed oxidative coupling of aromatic primary amines and alkenes under molecular oxygen: Stereoselective assembly of (Z)-enamines J. Org. Chem. 2013 38 11155 11162 10.1021/jo402117r 
84. Rashad M.  La Vecchia L.  Prasad K.  Repic O.   A convenient synthesis of 3-substituted 1H-indoles Synth. Commun. 1995 25 95 100 10.1080/00397919508010793 
85. Yoo W.J.  Capdevila M.G.  Du X.  Kobayashi S.   Base-mediated carboxylation of unprotected indole derivatives with carbon dioxide Org. Lett. 2012 14 5326 5329 10.1021/ol3025082 23035967